Navigation Links
Feeling Stressed?
Date:11/8/2007

ice so we can make further adjustments in their treatment. I find that initially giving them the power to fix the problem is very empowering to them."

In addition, Dr. Mayoral offered tips to curb the effects of stress both internally and externally:

-- Learn to recognize the underlying problem that is triggering your

symptoms and develop skills to help minimize the stress.

-- Exercise helps release endorphins in the body that can reduce stress.

-- Avoid very hot showers or baths and use detergent-free soaps.

Moisturize as soon as possible after bathing.

-- Wear a broad-spectrum sunscreen with an SPF of 15 or higher daily to

protect your skin from sun exposure.

For more information on skin, hair and nail conditions that can be affected by stress, visit http://www.skincarephysicians.com, a Web site developed by dermatologists that provides patients with up-to-date information on the treatment and management of disorders of the skin, hair and nails.

Headquartered in Schaumburg, Ill., the American Academy of Dermatology (Academy), founded in 1938, is the largest, most influential, and most representative of all dermatologic associations. With a membership of more than 15,000 physicians worldwide, the Academy is committed to: advancing the diagnosis and medical, surgical and cosmetic treatment of the skin, hair and nails; advocating high standards in clinical practice, education, and research in dermatology; and supporting and enhancing patient care for a lifetime of healthier skin, hair and nails. For more information, contact the Academy at 1-888-462-DERM (3376) or http://www.aad.org.


'/>"/>
SOURCE American Academy of Dermatology
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine news :

1. Forget the Old Stereotypes - New Survey Reveals that Baby Boomers Are Feeling More Young and Active than Ever!
2. Its More Than the Turkey Dinner That Will Leave You Feeling Bloated This Thanksgiving
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 2China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 3China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 4China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 5China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 6China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 7China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 8OrBIT Study Long Term Results Show Sustained Therapeutic Effect of Percutaneous Tibial Nerve Stimulation at 12 Months 2OrBIT Study Long Term Results Show Sustained Therapeutic Effect of Percutaneous Tibial Nerve Stimulation at 12 Months 3OrBIT Study Long Term Results Show Sustained Therapeutic Effect of Percutaneous Tibial Nerve Stimulation at 12 Months 4Arrayit Diagnostics Announces Sponsored Research Agreement With Wayne State University and Arrayit Corporation 2Arrayit Diagnostics Announces Sponsored Research Agreement With Wayne State University and Arrayit Corporation 3Arrayit Diagnostics Announces Sponsored Research Agreement With Wayne State University and Arrayit Corporation 4Medical Technology Executives Descend on D C as AdvaMed 2009 3A The MedTech Conference Kicks Off and Health Care Debate Continues 5384 1Medical Technology Executives Descend on D C as AdvaMed 2009 3A The MedTech Conference Kicks Off and Health Care Debate Continues 5384 2Medical Technology Executives Descend on D C as AdvaMed 2009 3A The MedTech Conference Kicks Off and Health Care Debate Continues 5384 3CSL Behring Announces FDA Approval of Berinert 28R 29 First and Only Therapy Approved for the Treatment of Acute Abdominal and Facial Attacks of Here 5379 1CSL Behring Announces FDA Approval of Berinert 28R 29 First and Only Therapy Approved for the Treatment of Acute Abdominal and Facial Attacks of Here 5379 2CSL Behring Announces FDA Approval of Berinert 28R 29 First and Only Therapy Approved for the Treatment of Acute Abdominal and Facial Attacks of Here 5379 3CSL Behring Announces FDA Approval of Berinert 28R 29 First and Only Therapy Approved for the Treatment of Acute Abdominal and Facial Attacks of Here 5379 4CSL Behring Announces FDA Approval of Berinert 28R 29 First and Only Therapy Approved for the Treatment of Acute Abdominal and Facial Attacks of Here 5379 5A Little Cash Buys a Lot of Calories at the Corner Store 59282 1A Little Cash Buys a Lot of Calories at the Corner Store 59282 2